The death of a 21-year-old Westport woman in 2018 is at the center of a complaint removed to federal court in Connecticut this week involving GlaxoSmithKline’s mood-stabilizing drug lamotrigine, the generic version of Lamictal.

Attorneys at O’Sullivan McCormack Jensen & Bliss on Wednesday removed the product liability suit against the British pharmaceutical giant to Connecticut District Court. The suit was filed by Koskoff, Koskoff & Bieder on behalf of Alan Doran, administrator for the estate of Rachel Hope Doran.